ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

AI and Health Equity in California

June 25, 2024

Author(s):

Rachel Radwan

Explore key takeaways from the California Health Care Foundation discussion on artificial intelligence and its effect on health care delivery in California.

AI and Health Equity in California

This April, the California Health Care Foundation (CHCF) hosted a discussion on artificial intelligence (AI) and its effect on health care delivery in California. CHCF is an independent, nonprofit philanthropy working to improve the state's health care system and provide individuals with the care they need; especially those from communities that experience significant barriers to care.

The session’s moderator, Kara Carter, senior vice president of Strategy and Programs at CHCF, called out the potential of AI to transform health care in a positive way. According to Carter, AI can help doctors sift through mountains of data to diagnose diseases faster and more accurately, while making real-time updates to electronic medical records. This will allow physicians to reduce what Carter refers to as “pajama time” (time spent charting and reviewing patient notes early in the morning or late at night), while reducing burnout, and ultimately increasing job satisfaction. “Providers will be able to prioritize patient interactions even more,” Carter said.

Carter also emphasized the real risks AI poses, including concerns about data privacy, irresponsible oversight, inequitable access to the benefits it can bring, and algorithms that perpetuate bias and health inequity. Thus, Carter argues it is essential policy leaders ensure that AI is responsibly deployed to the benefit of the public. “The goal of AI should be to support and augment the workforce instead of replacing it, and to build trust instead of suspicion in the health care system,” she said.

AI Opportunities in the Safety Net

Following her address, Carter welcomed keynote speaker, Mark Ghaly, MD, MPH, secretary, California Health and Human Services. Dr. Ghaly’s discussion focused on the impact of AI on California’s safety net: a grouping of programs and providers across the state that specialize in coverage and care for patients with low incomes, no insurance, and/or special medical needs.

According to Dr. Ghaly, adopting new technologies is typically delayed for providers within the safety net when compared to larger organizations with more resources. Even today, not all providers within the safety net are using an electronic health record (EHR). Thus, Dr. Ghaly emphasized that this trend must not be replicated with the adoption of AI.

Dr. Ghaly believes it is important to balance both the fears and the optimism of emerging technologies. “One of the areas that we have significant fear around,” Dr. Ghaly said, “is whether the government can actually create a regulatory framework that supports and secures equity, quality, and access in all the ways we can imagine.” These are valid concerns, that invite and enlist policymakers to pave the way for responsible and equitable use of AI across all communities.

Dr. Ghaly also provided a useful case for AI in the form of a community health worker. Daily, they may use AI to capture notes during visits with clients, to make better sense of the data collected during those visits, or to develop culturally competent and linguistically appropriate follow-up. “[It] requires us to look at tools like AI and other technologies not with fear, but with confidence that together, we can imagine ways to use it more effectively,” he noted.

To prevent the misuse of AI, Dr. Ghaly spoke to the need for core values that guide the deployment of AI tools, including addressing health inequities, promoting accountability and transparency, generating demonstrated value, empowering human capacity, strengthening community, cultivating innovation, and improving accessibility. In response to health care workers’ worry that AI will replace their roles, Dr. Ghaly called on policymakers and leaders to guide those conversations and be sensitive to the workforce impacts of AI. “This technology shouldn’t be a threat to jobs, but an aide for health care workers to free up their time for the more fulfilling, patient-facing aspects of their roles,” he said.

Dr. Ghaly closed by reiterating the importance of collaboration as the health care continuum works to leverage emerging technologies to build a better future and improve outcomes for all patients.

Framing AI

Next, panelists Susan Ehrlich, MD, MPP, CEO of the Priscilla Chan and Mark Zuckerberg San Francisco General Hospital and Trauma Center, and professor of medicine, UCSF; Carolina Reyes, MD, associate clinical professor, Maternal Fetal Medicine, School of Medicine, UC Davis Health, chair of the board of directors of the California Health Care Foundation, and board member of Common Spirit Health; and David Lubarsky, MD, MBA, FASA, vice chancellor of Human Health Sciences and chief executive officer, UC Davis Health, were invited to speak about their experiences using AI in their respective programs.

Dr. Lubarsky discussed trust as a significant barrier to the practical implementation of AI. “The speed of trust determines the speed of change,” he said. “You can’t get anywhere unless people actually believe AI is a good thing.” He also expressed that this resistance is often healthy and necessary, especially when providers demand proof that new technology will not negatively affect patient safety and care.

Dr. Lubarsky then reframed AI as “augmented intelligence” rather than artificial intelligence. “It is not artificial,” he explained. “It simply processes large amounts of data more quickly and accurately than a human can do on their own.” He echoed Dr. Ghaly’s sentiment that AI should be viewed as an assistant—not a replacement—for health care workers, capable of drawing their attention to what needs to be done.

Equity Concerns

Carter then posed the question of how the health care community can ensure these benefits of AI reach all communities in California, not just the wealthy ones. Dr. Ehrlich acknowledged that AI requires vast resources in the form of expertise, time, and money. She also expressed that her hospital, Zuckerberg San Francisco General, has witnessed the effects of the disparity in resources firsthand. “We’re watching our colleagues at UCSF move far ahead of us in their ability to take advantage of these technologies—AI, machine learning—just because they have more resources than we do,” Dr. Ehrlich said.

Dr. Reyes added that in the discussion of AI implementation, it is crucial for providers to keep their guiding principles at the forefront. If a new tool or method doesn’t allow them to treat patients with dignity and give them the best care possible, it should not be used. She was also hopeful that the introduction of AI will allow patient interactions to be much more focused on the whole health of the person, rather than a single symptom: “It’s really about the provider having that full data around that 1 individual patient…How do you incorporate the data knowing where that patient lives, what their situation is like, and their health condition to know what has worked and what hasn’t worked for that patient."

Building Trust in the Community

According to a recent survey by CHCF, more than 50% of Californians have expressed concern about AI being used in their health care. In response, Dr. Lubarsky emphasized the need for providers to be always transparent and accountable. Further, he believes that organizations who have successfully used AI need to share their results with everyone. “It’s not a competitive advantage to take better care of a patient,” he explained. “It’s a moral imperative.”

Dr. Reyes concluded by highlighting that the importance of every level of the workforce, from clerical workers up to the executive level, to have the cognitive and ethical skills to make judgment calls where AI is concerned—rather than assuming everything an AI tool produces is accurate.

Related Content

Extending Patient-Centered Cancer Care to Transgender and Nonbinary IndividualsACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Gabrielle Stearns

June 30, 2026

Transforming Oncology Authorization Through Clinical and Revenue Cycle CollaborationACCCBuzz Blog

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Rachel Radwan

June 29, 2026

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

MDS: Low Risk Isn’t No Risk - [Podcast] Ep. 239

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login